blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

MASH genetics: Key variants driving fatty liver risk

Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a progressive liver disease driven by fat a...
Continue reading

Pharmacogenomics testing: Safer dosing and reduced ADR risk

Pharmacogenomics, also known as pharmacogenetics, is a field of research dedicated to investigating how an individual's genetic makeup influences their response...
Continue reading

Webinar recap: The evolving landscape of liver disease

This webinar, hosted by Sano CEO Dr. Patrick Short and featuring Dr. Dimitar Tonev, an expert in liver disease and hepatology, sheds light on the latest develop...
Continue reading

Bolstering patient engagement to drive retention success

Keeping participants engaged in clinical research can be difficult. Here, we let the statistics tell the story:
Continue reading

Phenotypic data: Why genetic data needs context in research

Genetic data is at the heart of precision medicine. Understanding the influence of genetics on health has helped us to identify risk factors for disease, predic...
Continue reading

DPharm recap: Participant experience and incentives in focus

DPharm 2023 has come to a close, and as we reflect on the sessions and insights shared, two themes clearly stood out this year: The participant experience and i...
Continue reading

COVID-19 and genomic sequencing: Tracking variants and lessons for future pandemics

As COVID-19 continues to affect us all, it has become evident that our fight against the virus is not just about developing vaccines and therapeutics. Equally c...
Continue reading

Can ALS be Caught Early: Unravelling the Detection of ALS

In this blog, we're exploring whether ALS can be caught early, including the tests that may be used in order to diagnose ALS, and if there are any measures that...
Continue reading

Drug target discovery: Genetic data to clinical trials

The success of any precision medicine program depends on the quality of the target it pursues. A well-validated genetic target shapes everything downstream: whi...
Continue reading

The long haul: How long COVID continues to challenge healthcare

Long COVID, affecting nearly 28% of COVID-19 survivors, is a multifaceted condition that extends well beyond its initial impact. Typical include fatigue, concen...
Continue reading